Protective role of pulmonary nitric oxide in the acute phase of endotoxemia in rats

Circulation Research

Volumn 82, Issue 7, 1998, Pages 819-827

  Gryglewski, Ryszard J ^a   Wolkow, Pawel P ^a   Uracz, Wojciech ^a   Janowska, Ewa ^a   Bartus, Joanna B ^a   Balbatun, Oleg ^a   Patton, Stephen ^b   Brovkovych, Viktor ^b   Malinski, Tadeusz ^b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

Lung; Microcirculation; Shock

Indexed keywords

1 AMINO 2 HYDROXYGUANIDINE; BEPAFANT; CAMONAGREL; LIPOPOLYSACCHARIDE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE A2; THROMBOXANE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; HYPOTENSION; LUNG PARENCHYMA; MEAN ARTERIAL PRESSURE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM;

EID: 0032550248     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.82.7.819     Document Type: Article

References (28)

1. Oh-Ishi S, Ishida H, Ueno A. Role of synergistic action of PAF and kinin in bacterial endotoxin-induced hypotension in rats. Adv Exp Med Biol. 1996;416:235-238.
2. Fleming I, Dambacher T, Busse R. Endothelium-derived kinins account for the immediate response of endothelial cells to bacterial lipopolysaccharide. J Cardiovasc Pharmacol. 1992;20(suppl 12):S135-S138.
3. Parratt JR. Nitric oxide and cardiovascular dysfunction in sepsis and endotoxaemia: an introduction and an overview. In: Schlag G, Redl H, eds. Shock, Sepsis and Organ Failure: Nitric Oxide. New York, NY: Springer Verlag; 1995:1-29.
4. Knoles RG, Moncada S. Nitric oxide synthase in mammals. Biochem J. 1994;298:249-258.
5. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res. 1994;28:34-39.
6. Laszlo F, Whittle BJR, Moncada S. Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors. Br J Pharmacol. 1994;111:1309-1315.
7. Katusic ZS, Vanhoutte PM. Superoxide is an endothelium-derived contracting factor. Am J Physiol. 1989;357:H33-H37.
8. Huie RE, Padmaja S. The reaction rate of nitric oxide with superoxide. Free Radic Res Commun. 1993;18:195-199.
9. Kiechle FL, Malinski T. Indirect detection of nitric oxide effects: a review. Ann Clin Lab Sci. 1996;26:501-511.
10. Gryglewski RJ, Korbut R, Trabka Janik E, Zembowicz A, Trybulec M. Interaction between NO donors and iloprost in human vascular smooth muscle, platelets, and leukocytes. J Cardiovasc Pharmacol. 1989; 14(suppl 11):S124-S128.
11. Burck H. Weigert technique. In: Hans-Christian Burck, ed. Histologische Technik. Stuttgart, Germany: Georg Thieme Verlag; 1973:166.
12. Vallance P, Patton S, Bhagat K, MacAllister R, Radomski M, Moncada S, Malinski T. Direct measurement of nitric oxide in human beings. Lancet. 1995;346:153-154.
13. Malinski T, Taha Z. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature. 1992;358:676-678.
14. Mesaros S, Grunfeld S, Mesarosova A, Bustin D, Malinski T. Determination of nitric oxide saturated (stock) solution by chronoamperometry on a porphyrine microelectrode. Anal Chim Acta. 1997;339:265-270.
15. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II: analysis and examples. Br J Cancer. 1977;35:1-39.
16. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, I: introduction and design. Br J Cancer. 1976;34:585-612.
17. Zembala M, Mytar B, Ruggiero I, Uracz W, Popiela T, Czupryna A. Suppressor cells and survival of patients with advanced gastric cancer. J Natl Cancer Inst. 1983;70:223-228.
18. Huk I, Nanobashvili J, Neumayer C, Punz A, Mueller M, Afkhampour K, Mittlboeck M, Losert U, Polterauer P, Roth E, Patton S, Malinski T. L-Arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation. 1997;96:667-675.
19. Zhang ZG, Chopp M, Bailey F, Malinski T. Nitric-oxide changes in the rat-brain after transient middle cerebral-artery occlusion. J Neurol Sci. 1995;128:22-27.
20. Hampl V, Cornfield DN, Cowan NJ, Archer SL. Hypoxia potentiates nitric oxide synthesis and transiently increases cytosolic calcium levels in pulmonary artery endothelial cells. Eur Respir J. 1995;8:515-522.
21. Beckman JS, Chen J, Ischiropoulos H, Crow JP. Oxidative chemistry of peroxynitrite. Methods Enzymol. 1994;233:229-240.
22. Gryglewski RJ, Szczeklik A, Korbut R, Swies J, Musial J, Krzanowski M, Maga P. The mechanism of anti-thrombotic, thrombolytic and fibrinolytic actions of camonagrel: a new thromboxane synthase inhibitor. Wien Klin Wochenschr. 1995;107:283-289.
23. Casals Stenzel J. Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock. Eur J Pharmacol. 1987; 135:117-122.
24. Weir EK, Mlczoch J, Reeves JT, Graver RF. Endotoxin and prevention of hypoxic pulmonary vasoconstriction. J Lab Clin Med. 1976;88:975-983.
25. 2. J Clin Invest. 1983;71:351-357.
26. Uhlig S, Wollin L, Wendel A. Contributions of thromboxane and leukotrienes to PAF-induced impairment of lung function in the rat. J Appl Physiol. 1994;77:262-269.
27. Wizemann TM, Gardner CR, Laskin JD, Quinones S, Durham SK, Goller NL, Ohnishi ST, Laskin DL. Production of nitric oxide and peroxynitrite in the lung during acute endotoxemia. J Leukoc Biol. 1994;56:759-768.
28. Wu CC, Chen SJ, Szabo C, Thiemermann C, Vane JR. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol. 1995;114:1666-1672.